(Q33400931)

26 July 2017

title

Discovery of a new biomarker for the mucopolysaccharidoses (MPS), dipeptidyl peptidase IV (DPP-IV; CD26), by SELDI-TOF mass spectrometry (English)

1 reference

26 July 2017

0 references

Clare E Beesley

1

1 reference

26 July 2017

Elisabeth P Young

2

1 reference

26 July 2017

Niamh Finnegan

3

1 reference

26 July 2017

Marie Jackson

4

1 reference

26 July 2017

Kevin Mills

5

1 reference

26 July 2017

Ashok Vellodi

6

1 reference

26 July 2017

Maureen Cleary

7

1 reference

26 July 2017

Bryan G Winchester

8

1 reference

26 July 2017

publication date

18 January 2009

1 reference

Molecular Genetics and Metabolism

26 July 2017

published in

1 reference

26 July 2017

volume

96

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

218-224

1 reference

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Growth of ectopic dendrites on cortical pyramidal neurons in neuronal storage diseases correlates with abnormal accumulation of GM2 ganglioside.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Heparin cofactor II–thrombin complex in MPS I: A biomarker of MPS disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Heparin cofactor II–thrombin complex: A biomarker of MPS disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Innate and adaptive immune activation in the brain of MPS IIIB mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Regulation of protein function by glycosaminoglycans--as exemplified by chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

The role of heparan sulphate in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

The multifunctional or moonlighting protein CD26/DPPIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Dipeptidyl peptidase IV (DP IV) activity in serum and on lymphocytes of MRL/Mp-lpr/lpr mice correlates with disease onset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Secondary skeletal involvement in Sanfilippo syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.12.002

10.1016/J.YMGME.2008.12.002

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference